Login / Signup

Intravenous peramivir vs oral oseltamivir in high-risk emergency department patients with influenza: Results from a pilot randomized controlled study.

Yu-Hsiang HsiehAndrea F DugasFrank LoVecchioBreana McBrydeErin P RickettsKathryn Saliba-ShawRichard E Rothman
Published in: Influenza and other respiratory viruses (2020)
Clinical outcomes of influenza-infected patients treated with single-dose IV peramivir were comparable to those treated with oral oseltamivir, suggesting potential utility of peramivir for influenza-infected patients in the ED.
Keyphrases
  • emergency department
  • high dose
  • risk assessment